- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Dec 6, 2019 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Dec 6, 2019 | T-1187-19 | CMC | Bayer Inc. And Other V. Dr. Reddy's Laboratories Ltd And Others (Patent - Rivaroxaban*) | Ottawa | 1 h |
| Dec 6, 2019 | T-1008-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-1007-19 | CMC | Hoffmann-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-943-19 | CMC | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-942-19 | CMC | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-941-19 | CMC | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-939-19 | CMC | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-899-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-898-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-897-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-896-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-770-19 | CMC | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-768-19 | CMC | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-708-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-706-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 30 m |
| Dec 6, 2019 | T-705-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-704-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 30 m |
| Dec 6, 2019 | T-1642-16 | CMC | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Toronto | 1 h |
| Dec 6, 2019 | T-713-17 | M | Worthware Systems International Inc. V. Raysoft Inc. (Patent) | Montréal | 3 h |
| Dec 6, 2019 | T-1529-18 | TMC | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Ottawa | 1.5 h |
| Dec 6, 2019 | T-1527-18 | TMC | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Ottawa | 1.5 h |
| Dec 9, 2019 | T-1642-16 | Moti | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Calgary | 2.5 h |
| Dec 9, 2019 | T-449-17 | M | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 1 d |
| Dec 9, 2019 | T-1185-17 | CMC | Kim Laurie Shallcross V. Chrysalis Energies Corporation Et Al (Patent) | Toronto | 30 m |
| Dec 9, 2019 | T-1221-19 | CMC | Bayer Inc. Et Al. V. Accord Healthcare Inc. (Patent - Rivaroxaban*) | Ottawa | 1 h |
| Dec 9, 2019 | T-741-18 | CMC | Amgen Inc. Et Al V. Pfizer Canada Ulc (Patent - Filgrastim*) | Toronto | 30 m |
| Dec 9, 2019 | T-152-17 | CMC | Milano Pizza Ltd. V. 6034799 Canada Inc Et Al (Trade Mark) | Ottawa | 1 h |
| Dec 10, 2019 | A-262-17 | APP | Jeremy Cooperstock V. United Airlines, Inc. Et Al (Trade-mark) | Ottawa | 1 d |
| Dec 10, 2019 | T-2085-16 | M | Enigmatus, S.r.o. V. Playtika Ltd. Et Al (Trade Mark) | Toronto | 1 d |
| Dec 10, 2019 | T-878-16 | CMC | Akausivik Inuit Family Health Team V. Tungasuvvingat Inuit (Copyright) | Toronto | 30 m |
| Dec 11, 2019 | T-1529-18 | M | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 2 h |
| Dec 11, 2019 | T-1527-18 | M | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 2 h |
| Dec 11, 2019 | T-1066-17 | CMC | T-rex Property Ab V. Pattison Outdoor Advertising Limited Partnership Et Al (Patent) | Montréal | 1.5 h |
| Dec 11, 2019 | T-2080-17 | CMC | Mainstreet Equity Corp. V. Canadian Mortgage Capital Corporation Et Al (Trade Mark) | Toronto | 30 m |
| Dec 12, 2019 | T-1479-19 | CMC | Ecore International Inc V Pliteq Inc. (Patent) | Ottawa | 1 h |
| Dec 12, 2019 | T-629-19 | CMC | Redwood Plastics And Rubber Corp. V Color Master Tiles Canada Ltd. (Patent) | Vancouver | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Nov 25, 2019 | T-377-16 | Biofert Manufacturing Inc. V. Agrisol Manufacturing Inc. And Others (Trade Mark) | Vancouver | 14 d |
| Dec 5, 2019 | T-1632-16 | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 12 d |
| Dec 5, 2019 | T-1631-16 | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 12 d |
| Dec 5, 2019 | T-1627-16 | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 12 d |
| Dec 5, 2019 | T-1623-16 | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 12 d |
| Jan 13, 2020 | T-1632-16 | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 20, 2020 | T-741-18 | Amgen Inc. Et Al V. Pfizer Canada Ulc (Patent - Filgrastim*) | Toronto | 10 d |
| Jan 20, 2020 | T-1627-16 | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 27, 2020 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 15 d |
| Jan 27, 2020 | T-1623-16 | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 5 d |
| Feb 3, 2020 | T-1631-16 | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 5 d |
| Feb 3, 2020 | T-546-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Et Al (Patent) | Montréal | 23 d |
| Feb 3, 2020 | T-353-18 | Janssen Inc. Et Al V. Teva Canada Limited (Patent - Paliperidone*) | Toronto | 15 d |
| Mar 2, 2020 | T-1163-18 | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - Fampridine*) | Toronto | 10 d |
| Mar 2, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Toronto | 10 d |
| Mar 9, 2020 | T-921-17 | Rovi Guides, Inc. Et Al V. Videotron Ltd. (Patent) | Toronto | 20 d |
| Mar 23, 2020 | T-168-18 | Lickerish, Ltd. V. Airg Inc. (Copyright) | Calgary | 5 d |
| Mar 30, 2020 | T-1529-18 | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Mar 30, 2020 | T-1527-18 | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Apr 20, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 10 d |
| Apr 20, 2020 | T-902-19 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 10 d |
| May 4, 2020 | T-569-17 | J.r. Simplot Company V. Mccain Foods Ltd. V. Simplot Canada (ii) Limited (Trade Mark) | Ottawa | 7 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| May 25, 2020 | T-206-18 | Rovi Guides, Inc. Et Al V. Telus Corporation Et Al (Patent) | Toronto | 20 d |
| May 25, 2020 | T-113-18 | Rovi Guides Inc Et Al V. Bce Inc. Et Al (Patent) | Toronto | 20 d |
| Jun 1, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 14 d |
| Jun 15, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 10 d |
| Jul 15, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Ottawa | 3 d |
| Aug 24, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 24, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 31, 2020 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 14 d |
| Sep 1, 2020 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-205-19 | Triteq Lock & Security, Llc V. Minus Forty Technologies Corp. (Patent) | Toronto | 5 d |
| Sep 17, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Toronto | 2 d |
| Sep 21, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 2 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
| Oct 13, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Toronto | 2 d |
| Oct 19, 2020 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Oct 19, 2020 | T-65-19 | Novo Nordisk A/s Et Al V. Teva Canada Limited (Patent - Liraglutide*) | Toronto | 10 d |
| Oct 26, 2020 | T-978-19 | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-182-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-84-19 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Nov 16, 2020 | T-630-18 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 10 d |
| Nov 23, 2020 | T-917-17 | Sse Holdings, Llc Et Al V. Le Chic Shack Inc. (Trade Mark) | Québec | 5 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Nov 30, 2020 | T-1158-18 | Maoz Betser-zilevitch V. Petrochina Canada Ltd. (Patent) | Toronto | 12 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Dec 5, 2019 | T-784-19 | David Suzuki Foundation Et Al V. Minister Of Health Et Al & Croplife Canada | S. 18.1 Application for Judicial Review | Toronto | 2 d |
| Dec 16, 2019 | A-383-19 | Rovi Guides, Inc. Et Al V. Videotron G.p. Et Al | Appeal (S.27 - Interloc.) - Patent Act [from T-921-17 - Patent Infringement] | Ottawa | 1 d |
| Jan 13, 2020 | T-1736-18 | Obsidian Group Inc. V. The Attorney General Of Canada | S. 18.1 Application for Judicial Review | Toronto | 4 h |
| Jan 15, 2020 | T-353-19 | Viiv Healthcare Ulc V. The Minister Of Health - Dolutegravir* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jan 28, 2020 | T-1342-19 | Blue Seal Inc. V Lourens Poorter | Trade Mark Opposition | Vancouver | 1 h |
| Feb 18, 2020 | T-926-19 | Pentastar Transportation Ltd V. Fca Us Llc | Trade Mark Opposition | Ottawa | 4 h |
| Mar 2, 2020 | T-1564-19 | Inguran Llc Dba Stgenetics V. Commissioner Of The Patents | Patent - Correction of Register | Ottawa | 2 h |
| Apr 27, 2020 | T-1465-19 | Innovative Medicines Canada Et Al V. Agc | S. 18.1 Application for Judicial Review | Toronto | 2 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Dec 10, 2019 | A-262-17 | Jeremy Cooperstock V. United Airlines, Inc. Et Al | Appeal (S.27 - Final) - Trade-marks Act [from T-2084-12 - Trade Mark Infringement] | Ottawa | 1 d |
| Dec 16, 2019 | A-242-19 | Labrador-island Link General Partner Corp. Et Al. V. Panalpina Inc. Et Al. | Appeal (S.27 - Final) - Admiralty [from T-722-17 - Copyright Infringement [Actions]] | Montréal | 3 h |
| Dec 16, 2019 | A-92-19 | Canadian National Railway Company V. Bnsf Railway Company | Appeal (S.27 - Interloc.) - Patent Act [from T-913-17 - Patent Infringement] | Montréal | 1 h |
| Jan 13, 2020 | A-388-19 | Apotex Inc. V. Bayer Inc. Et Al - Rivaroxaban* | Appeal (S.27 - Interloc.) - Others [from T-1960-18 - Patented Medicines (NOC) Regulations [Actions]] | Toronto | 3 h |
| Jan 13, 2020 | A-389-19 | Teva Canada Limited V. Bayer Inc Et Al | Appeal (S.27 - Final) - Patent Act | Toronto | 3 h |
| Jan 15, 2020 | A-141-18 | The Clorox Company Of Canada, Ltd. V. Chloretec S.e.c. | Appeal (S.27 - Final) - Trade-marks Act [from T-712-16 - Trade Mark - Appeal of a decision of the Registrar] | Toronto | 2 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.